Pharma Recall: Stop Using Zantac Now

Shipments Of A Generic Zantac Halted After FDA Warns Of Low Level Probable Carcinogen In Zantac And Its Generic Version

The FDA is urging the popular heartburn medicine Zantac to be taken off the market because it was found to contain the cancer-causing chemical NDMA.

Stores have been asked to remove all prescription and over-the-counter versions of Zantac from their shelves, and anyone who has it at home should throw it out immediately. The FDA explained, "The agency has determined that the impurity in some ranitidine products increases over time when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity."

Some safe alternatives being suggested for heartburn sufferers include Pepcid, Tagamet, Nexium, Prevacid and Prilosec.


Getty Images

Sponsored Content

Sponsored Content